HeartBeam, Inc. (BEATW): R&D Expense
$13.45M
Year ended 2025-12-31
$11.33M
Trailing 12 months to 2026-06-30
+33.3%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.45M | +21.7% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $11.05M | +62.6% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $6.80M | +19.7% | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $5.68M | n/m | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | $255.0K | +91.7% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $133.0K | n/a | 2022-03-24, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| HeartBeam, Inc. (BEATW) | 2025-12-31 | $13.45M | +21.7% |
| Aethlon Medical Inc (AEMD) | 2026-03-31 | $1.91M | -13.6% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $7.50M | +18.6% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $2.76M | +28.2% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $149.9K | +64.4% |
| Bluejay Diagnostics, Inc. (BJDX) | 2025-12-31 | $3.05M | -12.2% |
| Autonomix Medical, Inc. (AMIX) | 2026-03-31 | $7.14M | +51.2% |
| Glucotrack, Inc. (GCTK) | 2025-12-31 | $9.81M | +3.3% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
Compare BEATW, AEMD, QTEX, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗